Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LAS VEGAS, NV--(Marketwired - September 11, 2017) - CV Sciences, Inc., (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we") has provided a webcast for the Company's shareholder update call on...
-
LAS VEGAS, NV--(Marketwired - September 06, 2017) - CV Sciences, Inc., (OTCQB: CVSI) (the "Company" or "CV Sciences"), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD)...
-
LAS VEGAS, NV--(Marketwired - September 05, 2017) - CV Sciences, Inc. (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announced today that its...
-
LAS VEGAS, NV--(Marketwired - August 28, 2017) - CV Sciences, Inc. (OTCQB: CVSI) ("CV Sciences," "our" or "we"), is pleased to announce today that they will be presenting at the MJAC2017 InvestorsHub...
-
LAS VEGAS, NV--(Marketwired - August 23, 2017) - CV Sciences, Inc., (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), today cited additional research suggesting cannabidiol (CBD) may be...
-
LAS VEGAS, NV--(Marketwired - August 15, 2017) - CV Sciences, Inc. (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we") highlighted a recent study conducted at Federal University of Prana and...
-
LAS VEGAS, NV--(Marketwired - August 09, 2017) - CV Sciences, Inc. (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced its Title Sponsorship of the 24th Annual Hemp...
-
LAS VEGAS, NV--(Marketwired - August 01, 2017) - CV Sciences, Inc., (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), cited a recent study conducted by researchers at the University of...
-
LAS VEGAS, NV--(Marketwired - July 25, 2017) - CV Sciences, Inc., (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived cannabidiol (CBD)...
-
LAS VEGAS, NV--(Marketwired - July 20, 2017) - CV Sciences, Inc. (OTCQB: CVSI) (the "Company," "CV Sciences," "our" or "we"), highlights a recent clinical study using pharmaceutical grade cannabidiol...